http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0840903-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4655b70cbfba352025a1d2393b449e77
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02
filingDate 1995-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23ae63caaed48c5a947808757bb12545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46ade21ab9dabcadd18e08ec38082847
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bffe5a7804dd4d23d7fb80b09c79266c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_193fdbcc5f06b237910ad43fe6aa29e8
publicationDate 1996-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H0840903-A
titleOfInvention Pharmaceutical composition for preventing peripheral neuropathy induced by anticancer drug
abstract (57) Abstract: A pharmaceutical composition for preventing peripheral neuropathy induced by an anticancer agent is provided. A pharmaceutical composition comprising eliprodil or its enantiomers as a free base or a pharmaceutically acceptable acid addition salt, and optionally an anticancer agent, together with a pharmaceutically acceptable excipient is provided with an anticancer agent. The pharmaceutical composition is useful for preventing induced peripheral neuropathy.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008136374-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009167164-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006503069-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9903350-A1
priorityDate 1994-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395834
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID40839
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506983
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419575906
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5978
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441203
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124516887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743287
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6167
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536599
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226518553
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID178359
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535677
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419499457
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450215120
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396057
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395833
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585571
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743293
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492855
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID249332
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395766

Total number of triples: 49.